{
  "experiment_info": {
    "experiment_name": "paper_13_Ovarian_Tumor",
    "run_number": 5,
    "total_runs": 10,
    "timestamp": "20250624_020624",
    "run_start_time": "2025-06-24T03:20:23.469221",
    "run_end_time": "2025-06-24T03:21:05.830917"
  },
  "inputs": {
    "initial_description": {
      "timestamp": "2025-06-24T03:20:23.469221",
      "data": {
        "description": "Ovarian cancer relapse is often characterized by metastatic spread throughout the peritoneal cavity with tumors attached to multiple organs. In this study, interaction of ovarian cancer cells with the peritoneal tumor microenvironment was evaluated in a xenograft model based on intraperitoneal injection of fluorescent SKOV3.ip1 ovarian cancer cells. Intra-vital microscopy of mixed GFP-red fluorescent protein (RFP) cell populations injected into the peritoneum demonstrated that cancer cells aggregate and attach as mixed spheroids, emphasizing the importance of homotypic adhesion in tumor formation. Electron microscopy provided high resolution structural information about local attachment sites. Experimental measurements from the mouse model were used to build a three-dimensional cellular Potts ovarian tumor model (OvTM) that examines ovarian cancer cell attachment, chemotaxis, growth, and vascularization. OvTM simulations provide insight into the relative influence of cancer cell\u2013cell adhesion, oxygen availability, and local architecture on tumor growth and morphology. Notably, tumors on the mesentery, omentum, or spleen readily invade the \u201copen\u201d architecture, while tumors attached to the gut encounter barriers that restrict invasion and instead rapidly expand into the peritoneal space. Simulations suggest that rapid neovascularization of SKOV3.ip1 tumors is triggered by constitutive release of angiogenic factors in the absence of hypoxia. This research highlights the importance of cellular adhesion and tumor microenvironment in the seeding of secondary ovarian tumors on diverse organs within the peritoneal cavity. Results of the OvTM simulations indicate that invasion is strongly influenced by features underlying the mesothelial lining at different sites, but is also affected by local production of chemotactic factors. The integrated in vivo mouse model and computer simulations provide a unique platform for evaluating targeted therapies for ovarian cancer relapse."
      }
    }
  },
  "llm_responses": [
    {
      "step": "llm_response",
      "timestamp": "2025-06-24T03:20:43.576910",
      "prompt": "Original description: Ovarian cancer relapse is often characterized by metastatic spread throughout the peritoneal cavity with tumors attached to multiple organs. In this study, interaction of ovarian cancer cells with the peritoneal tumor microenvironment was evaluated in a xenograft model based on intraperitoneal injection of fluorescent SKOV3.ip1 ovarian cancer cells. Intra-vital microscopy of mixed GFP-red fluorescent protein (RFP) cell populations injected into the peritoneum demonstrated that cancer cells aggregate and attach as mixed spheroids, emphasizing the importance of homotypic adhesion in tumor formation. Electron microscopy provided high resolution structural information about local attachment sites. Experimental measurements from the mouse model were used to build a three-dimensional cellular Potts ovarian tumor model (OvTM) that examines ovarian cancer cell attachment, chemotaxis, growth, and vascularization. OvTM simulations provide insight into the relative influence of cancer cell\u2013cell adhesion, oxygen availability, and local architecture on tumor growth and morphology. Notably, tumors on the mesentery, omentum, or spleen readily invade the \u201copen\u201d architecture, while tumors attached to the gut encounter barriers that restrict invasion and instead rapidly expand into the peritoneal space. Simulations suggest that rapid neovascularization of SKOV3.ip1 tumors is triggered by constitutive release of angiogenic factors in the absence of hypoxia. This research highlights the importance of cellular adhesion and tumor microenvironment in the seeding of secondary ovarian tumors on diverse organs within the peritoneal cavity. Results of the OvTM simulations indicate that invasion is strongly influenced by features underlying the mesothelial lining at different sites, but is also affected by local production of chemotactic factors. The integrated in vivo mouse model and computer simulations provide a unique platform for evaluating targeted therapies for ovarian cancer relapse.\n\nClarifications provided: \n\n\n    Return ONLY a JSON object with ontology annotations. Format all IDs and terms exactly as specified in the system message.",
      "system_message": "You are a biological modeling expert. Create structured ontology annotations based on the provided information. \n    Include relevant Cell Ontology, GO, and MeSH terms where applicable.\n    Return ONLY a JSON object with categories for different ontology types.\n    \n    Format requirements:\n    1. Category names must be exact:\n       - \"CellOntology\" (not \"Cell Ontology\" or \"Cell  Ontology\")\n       - \"GeneOntology\" (not \"Gene Ontology\" or \"Gene  Ontology\")\n       - \"MeSH\" (not \"MeSH Terms\" or \"MeSH  Terms\")\n    \n    2. Ontology IDs must be exact without spaces:\n       - Cell Ontology: \"CL:0000000\" (not \"CL : 000 000 0\")\n       - Gene Ontology: \"GO:0000000\" (not \"GO : 000 000 0\")\n       - MeSH: \"D000000\" (not \"D 000 000\")\n    \n    3. Term names must be exact without extra spaces:\n       - \"Epithelial\" (not \"Ep ith elial\")\n       - \"Mesenchymal\" (not \"Mes ench ym al\")\n    \n    Example format:\n    {\n        \"CellOntology\": [\n            {\n                \"id\": \"CL:0000000\",\n                \"term\": \"Epithelial\"\n            }\n        ],\n        \"GeneOntology\": [\n            {\n                \"id\": \"GO:0000000\",\n                \"term\": \"Cell Division\"\n            }\n        ],\n        \"MeSH\": [\n            {\n                \"id\": \"D000000\",\n                \"term\": \"Cell Proliferation\"\n            }\n        ]\n    }\n    \n    Do not include any explanations or thinking process.",
      "response": "<think>\nOkay, let's start by breaking down the original description to identify relevant ontology terms. The study focuses on ovarian cancer relapse, specifically looking at metastatic spread in the peritoneal cavity using SKOV3.ip1 cells. They mention homotypic adhesion, tumor microenvironment, cellular adhesion, chemotaxis, vascularization, and invasion. \n\nFor Cell Ontology (CellOntology), the main cell type here is ovarian cancer cells. The Cell Ontology term for that is \"malignant cell\" with CL:0001064. Also, since they mention epithelial and mesenchymal aspects in adhesion and invasion, but the exact terms aren't in the text. Wait, the original text doesn't explicitly say \"epithelial\" or \"mesenchymal\" cells, but ovarian cancer cells are typically epithelial in origin. Maybe \"CL:0000066 Epithelial Cell\" is applicable here. Alternatively, \"malignant cell\" might be more accurate.\n\nGene Ontology (GeneOntology) terms would include processes like cell adhesion (GO:0007155), chemotaxis (GO:0006935), angiogenesis (GO:0001525), and response to hypoxia (GO:0001666). The study talks about homotypic adhesion, which is cell-cell adhesion. They also mention vascularization triggered by angiogenic factors, so angiogenesis is relevant. Hypoxia is mentioned in the context of constitutive release of angiogenic factors in its absence, so maybe response to hypoxia isn't directly involved, but since they mention oxygen availability, perhaps \"response to oxygen levels\" (GO:0070482) or \"cellular response to hypoxia\" (GO:0071456). Wait, the study says that neovascularization is triggered without hypoxia, so maybe the process here is angiogenesis (GO:0001525) and cell adhesion (GO:0007155). Also, tumor growth involves cell proliferation (GO:0008283), but the description mentions growth, so that's another term.\n\nFor MeSH terms, looking at the topics covered: ovarian neoplasms (D010051), neoplasm metastasis (D009362), tumor microenvironment (D060526), neovascularization, pathologic (D018866), and cell adhesion (D015815). The study is about ovarian cancer relapse and metastasis, so these terms fit. Also, peritoneal cavity (D010537) might be relevant, but MeSH terms should focus on the main concepts like the tumor microenvironment and metastasis.\n\nNow, checking the exact IDs and term names. CellOntology: \"malignant cell\" is CL:0001064. Epithelial cell is CL:0000066, but since the cells are ovarian cancer cells which are malignant, CL:0001064 is more accurate. However, if the study emphasizes epithelial characteristics, maybe include both. Wait, the original text doesn't specify epithelial transition, but SKOV3.ip1 cells are derived from ovarian adenocarcinoma, which is epithelial. So maybe \"Epithelial Cell\" CL:0000066 and \"Malignant Cell\" CL:0001064. But the problem is the user might expect only the most relevant terms. The study talks about homotypic adhesion, which is a feature of epithelial cells. So perhaps both terms are applicable. But I need to check if \"Epithelial\" is a term in Cell Ontology. Looking up, \"epithelial cell\" is CL:0000066. So including that. Also, the term \"Mesenchymal\" is mentioned in the user's example, but the text doesn't explicitly state mesenchymal cells, so maybe not include that unless implied. The study mentions invasion, which can involve epithelial-mesenchymal transition, but unless specified, better not to include. So CellOntology would have \"Epithelial Cell\" and \"Malignant Cell\".\n\nGeneOntology: Cell-cell adhesion (GO:0007155), Angiogenesis (GO:0001525), Chemotaxis (GO:0006935), and maybe Cell proliferation (GO:0008283). The study also mentions vascularization, which is angiogenesis. They built a model examining growth, so cell proliferation is relevant. Also, response to oxygen levels (GO:0070482) since oxygen availability is mentioned. But the exact term for oxygen availability's effect might be \"cellular response to oxygen levels\" (GO:0070482). Alternatively, \"response to hypoxia\" (GO:0001666) is mentioned in the context of its absence. So maybe include \"angiogenesis\" (GO:0001525), \"cell-cell adhesion\" (GO:0007155), \"chemotaxis\" (GO:0006935), and \"cell proliferation\" (GO:0008283).\n\nMeSH terms: Ovarian Neoplasms (D010051), Neoplasm Metastasis (D009362), Tumor Microenvironment (D060526), Neovascularization, Pathologic (D018866), Cell Adhesion (D015815). These all align with the study's focus on metastasis, tumor environment, vascularization, and adhesion. \n\nNow, ensuring that all IDs are correctly formatted without spaces, and term names are exact. For example, \"Cell-Cell Adhesion\" in GO is actually \"cell-cell adhesion\" with the ID GO:0016337. Wait, maybe I made a mistake here. Let me double-check. The GO term for cell-cell adhesion is GO:0098609, which is \"cell-cell adhesion via plasma-membrane adhesion molecules\". Alternatively, \"cell adhesion\" is GO:0007155. The original text mentions \"homotypic adhesion\", which is a type of cell-cell adhesion. So maybe \"cell adhesion\" (GO:0007155) is appropriate here. \n\nSimilarly, angiogenesis is GO:0001525. Chemotaxis is GO:0006935. Cell proliferation is GO:0008283. \n\nFor MeSH, \"Ovarian Neoplasms\" is D010051. \"Neoplasm Metastasis\" is D009362. \"Tumor Microenvironment\" is D060526. \"Neovascularization, Pathologic\" is D018866. \"Cell Adhesion\" is D015815.\n\nPutting it all together in the JSON structure with the exact category names and formatting. Need to make sure no extra spaces in terms or IDs. Let me verify each term and ID again to be safe.\n</think>\n\n{\n    \"CellOntology\": [\n        {\n            \"id\": \"CL:0000066\",\n            \"term\": \"Epithelial Cell\"\n        },\n        {\n            \"id\": \"CL:0001064\",\n            \"term\": \"Malignant Cell\"\n        }\n    ],\n    \"GeneOntology\": [\n        {\n            \"id\": \"GO:0007155\",\n            \"term\": \"Cell Adhesion\"\n        },\n        {\n            \"id\": \"GO:0006935\",\n            \"term\": \"Chemotaxis\"\n        },\n        {\n            \"id\": \"GO:0001525\",\n            \"term\": \"Angiogenesis\"\n        },\n        {\n            \"id\": \"GO:0008283\",\n            \"term\": \"Cell Proliferation\"\n        }\n    ],\n    \"MeSH\": [\n        {\n            \"id\": \"D010051\",\n            \"term\": \"Ovarian Neoplasms\"\n        },\n        {\n            \"id\": \"D009362\",\n            \"term\": \"Neoplasm Metastasis\"\n        },\n        {\n            \"id\": \"D060526\",\n            \"term\": \"Tumor Microenvironment\"\n        },\n        {\n            \"id\": \"D018866\",\n            \"term\": \"Neovascularization, Pathologic\"\n        },\n        {\n            \"id\": \"D015815\",\n            \"term\": \"Cell Adhesion\"\n        }\n    ]\n}"
    },
    {
      "step": "llm_response",
      "timestamp": "2025-06-24T03:21:05.786227",
      "prompt": "Generate a valid CompuCell3D simulation file based on these ontology annotations.\n    Return ONLY the Python code:\n\n{'CellOntology': {'Malignant Cell (CL:0001064)', 'Epithelial Cell (CL:0000066)'}, 'GeneOntology': {'Cell Proliferation (GO:0008283)', 'Angiogenesis (GO:0001525)', 'Chemotaxis (GO:0006935)', 'Cell Adhesion (GO:0007155)'}, 'MeSH': {'Ovarian Neoplasms (D010051)', 'Cell Adhesion (D015815)', 'Neoplasm Metastasis (D009362)', 'Neovascularization, Pathologic (D018866)', 'Tumor Microenvironment (D060526)'}}",
      "system_message": "You are a CompuCell3D expert. Generate a valid CompuCell3D simulation file.\n    Return ONLY the Python code without any additional text, explanations, or thinking process.\n    The code must include:\n    1. Required imports (CompuCellSetup, steppables)\n    2. A proper simulation class that inherits from steppables.SteppableBasePy\n    3. Required methods (__init__, start, step)\n    4. Basic cell types and parameters based on the ontology annotations",
      "response": "<think>\nOkay, I need to generate a CompuCell3D simulation Python file based on the given ontology annotations. Let me start by recalling the structure of a typical CompuCell3D script.\n\nFirst, the necessary imports: CompuCellSetup and the steppables module. That's straightforward. Then, the simulation class should inherit from SteppableBasePy. The class needs __init__, start, and step methods.\n\nLooking at the ontology annotations, there are two cell types: Malignant and Epithelial. So I'll define those in the start method. The gene ontology terms include cell proliferation, angiogenesis, chemotaxis, and adhesion. MeSH terms relate to ovarian neoplasms, metastasis, neovascularization, and tumor microenvironment. \n\nFor cell adhesion, I'll set adhesion parameters between the cell types. Maybe set different adhesion strengths. Proliferation can be handled by checking if a cell should divide based on a condition, like every certain number of steps. Chemotaxis might involve setting up a chemical field and directing cells to move along its gradient. Angiogenesis could be modeled by having some process related to endothelial cells or vascular growth, but since the cell types don't include endothelial, maybe that's part of the microenvironment. Perhaps add a secretion and chemotaxis towards a growth factor.\n\nIn the start method, I need to initialize cell types with their parameters. Then in the step method, handle cell division and update chemotaxis parameters each step. Also, maybe add a secretion field like VEGF for angiogenesis.\n\nWait, the user might expect the basic setup with those ontology terms. So include adhesion parameters for both cell types. For proliferation, use a simple division every some steps. For chemotaxis, use a chemical field and assign lambda. Maybe add a secretion in the step method for angiogenesis.\n\nI should set up the simulation with appropriate dimensions, cell types, adhesion energies, and include a chemical field. Also, in the step method, implement cell division at intervals and update chemotaxis. Maybe track cell volume or another property to trigger division.\n\nLet me structure the code:\n\n- Imports\n- Simulation class with __init__, start, step\n- In start, define cell types and their adhesion parameters, initialize some cells\n- In step, handle cell division (maybe every 100 steps) and chemotaxis\n- Set up a chemical field for chemotaxis (like a growth factor)\n- Include cell adhesion by setting neighbor adhesion energies\n- Possibly secretion of a chemical related to angiogenesis\n\nI think that covers the main points. Let me write the code accordingly, ensuring all required elements are included.\n</think>\n\n```python\nfrom pybindecs import CompuCellSetup\nfrom CompuCell import steppables\nimport CompuCell\n\nclass TumorSimulation(steppables.SteppableBasePy):\n    def __init__(self, simulator):\n        steppables.SteppableBasePy.__init__(self, simulator)\n        self.inventory = simulator.getPotts().getCellInventory()\n        self.cell_field = simulator.getPotts().getCellField()\n        \n    def start(self):\n        self.build_cell_types()\n        self.initialize_cells()\n        self.setup_chemotaxis()\n        \n    def build_cell_types(self):\n        self.malignant_type = self.add_cell_type(\"Malignant\")\n        self.epithelial_type = self.add_cell_type(\"Epithelial\")\n        \n        self.set_contact_energy(self.malignant_type, self.malignant_type, 10)\n        self.set_contact_energy(self.malignant_type, self.epithelial_type, 15)\n        self.set_contact_energy(self.epithelial_type, self.epithelial_type, 20)\n        \n        self.set_cell_adhesion_parameters(\n            cell_type=self.malignant_type,\n            lambda_chemotaxis=2.0,\n            target_chemical=\"VEGF\"\n        )\n        \n    def initialize_cells(self):\n        for _ in range(100):\n            cell = self.potts.createCell()\n            cell.type = self.malignant_type if CompuCell.rand_int(1,100) > 30 else self.epithelial_type\n            self.cell_field.placeCellAt(cell, *self.random_position())\n            \n    def step(self, mcs):\n        if mcs % 100 == 0:\n            self.handle_proliferation()\n            \n        if mcs % 50 == 0:\n            self.update_angiogenesis()\n            \n    def handle_proliferation(self):\n        for cell in self.inventory():\n            if cell.type == self.malignant_type and cell.volume > 20:\n                self.divide_cell_random_orientation(cell)\n                \n    def setup_chemotaxis(self):\n        self.add_chemical_field(\"VEGF\")\n        self.set_chemotaxis_params(\n            self.malignant_type,\n            \"VEGF\",\n            lambda_chemo=0.5,\n            positive_chemo=True\n        )\n        \n    def update_angiogenesis(self):\n        for cell in self.inventory():\n            if cell.type == self.malignant_type:\n                self.secrete_substance(cell, \"VEGF\", 0.1)\n\nCompuCellSetup.run()\n```"
    }
  ],
  "outputs": {},
  "metadata": {
    "experiment_model_type": "reasoning",
    "model_type": "reasoning",
    "model_name": "deepseek-ai/deepseek-r1",
    "thinking_process": "<think>\nOkay, I need to generate a CompuCell3D simulation Python file based on the given ontology annotations. Let me start by recalling the structure of a typical CompuCell3D script.\n\nFirst, the necessary imports: CompuCellSetup and the steppables module. That's straightforward. Then, the simulation class should inherit from SteppableBasePy. The class needs __init__, start, and step methods.\n\nLooking at the ontology annotations, there are two cell types: Malignant and Epithelial. So I'll define those in the start method. The gene ontology terms include cell proliferation, angiogenesis, chemotaxis, and adhesion. MeSH terms relate to ovarian neoplasms, metastasis, neovascularization, and tumor microenvironment. \n\nFor cell adhesion, I'll set adhesion parameters between the cell types. Maybe set different adhesion strengths. Proliferation can be handled by checking if a cell should divide based on a condition, like every certain number of steps. Chemotaxis might involve setting up a chemical field and directing cells to move along its gradient. Angiogenesis could be modeled by having some process related to endothelial cells or vascular growth, but since the cell types don't include endothelial, maybe that's part of the microenvironment. Perhaps add a secretion and chemotaxis towards a growth factor.\n\nIn the start method, I need to initialize cell types with their parameters. Then in the step method, handle cell division and update chemotaxis parameters each step. Also, maybe add a secretion field like VEGF for angiogenesis.\n\nWait, the user might expect the basic setup with those ontology terms. So include adhesion parameters for both cell types. For proliferation, use a simple division every some steps. For chemotaxis, use a chemical field and assign lambda. Maybe add a secretion in the step method for angiogenesis.\n\nI should set up the simulation with appropriate dimensions, cell types, adhesion energies, and include a chemical field. Also, in the step method, implement cell division at intervals and update chemotaxis. Maybe track cell volume or another property to trigger division.\n\nLet me structure the code:\n\n- Imports\n- Simulation class with __init__, start, step\n- In start, define cell types and their adhesion parameters, initialize some cells\n- In step, handle cell division (maybe every 100 steps) and chemotaxis\n- Set up a chemical field for chemotaxis (like a growth factor)\n- Include cell adhesion by setting neighbor adhesion energies\n- Possibly secretion of a chemical related to angiogenesis\n\nI think that covers the main points. Let me write the code accordingly, ensuring all required elements are included.\n</think>",
    "cc3d_file_creation": {
      "python_code": "from cc3d.core.PySteppables import *\n\nfrom pybindecs import CompuCellSetup\nfrom CompuCell import steppables\nimport CompuCell\n\nclass TumorSimulation(steppables.SteppableBasePy):\n    def __init__(self, simulator):\n        steppables.SteppableBasePy.__init__(self, simulator)\n        self.inventory = simulator.getPotts().getCellInventory()\n        self.cell_field = simulator.getPotts().getCellField()\n        \n    def start(self):\n        self.build_cell_types()\n        self.initialize_cells()\n        self.setup_chemotaxis()\n        \n    def build_cell_types(self):\n        self.malignant_type = self.add_cell_type(\"Malignant\")\n        self.epithelial_type = self.add_cell_type(\"Epithelial\")\n        \n        self.set_contact_energy(self.malignant_type, self.malignant_type, 10)\n        self.set_contact_energy(self.malignant_type, self.epithelial_type, 15)\n        self.set_contact_energy(self.epithelial_type, self.epithelial_type, 20)\n        \n        self.set_cell_adhesion_parameters(\n            cell_type=self.malignant_type,\n            lambda_chemotaxis=2.0,\n            target_chemical=\"VEGF\"\n        )\n        \n    def initialize_cells(self):\n        for _ in range(100):\n            cell = self.potts.createCell()\n            cell.type = self.malignant_type if CompuCell.rand_int(1,100) > 30 else self.epithelial_type\n            self.cell_field.placeCellAt(cell, *self.random_position())\n            \n    def step(self, mcs):\n        if mcs % 100 == 0:\n            self.handle_proliferation()\n            \n        if mcs % 50 == 0:\n            self.update_angiogenesis()\n            \n    def handle_proliferation(self):\n        for cell in self.inventory():\n            if cell.type == self.malignant_type and cell.volume > 20:\n                self.divide_cell_random_orientation(cell)\n                \n    def setup_chemotaxis(self):\n        self.add_chemical_field(\"VEGF\")\n        self.set_chemotaxis_params(\n            self.malignant_type,\n            \"VEGF\",\n            lambda_chemo=0.5,\n            positive_chemo=True\n        )\n        \n    def update_angiogenesis(self):\n        for cell in self.inventory():\n            if cell.type == self.malignant_type:\n                self.secrete_substance(cell, \"VEGF\", 0.1)\n\nCompuCellSetup.run()",
      "output_file": "experiments\\batch_reasoning_20250624_020624\\paper_13_Ovarian_Tumor_20250624_020624\\run_5\\generated_cc3d_model.cc3d"
    }
  }
}